NasdaqCM:LQDAPharmaceuticals
Liquidia (LQDA) Is Down 7.8% After Swing to Q2 Profit on Surging YUTREPIA Revenue - What's Changed
Liquidia Corporation recently reported past second-quarter 2026 results showing revenue of US$171.68 million versus US$8.84 million a year earlier, with net income of US$74.72 million replacing a prior net loss and basic earnings per share from continuing operations rising to US$0.84.
Over the first half of 2026, this shift from losses to profits and strong revenue expansion underscores how YUTREPIA’s commercialization and improved payer access are now translating more fully into the...